Related Experiment Video

Updated: May 5, 2026

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
08:50

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

Published on: April 18, 2025

1.0K

miR-122 regulates tumorigenesis in hepatocellular carcinoma by targeting AKT3

Rounak Nassirpour1, Pramod P Mehta, Min-Jean Yin

  • 1Oncology Research, Pfizer Worldwide Research and Development, San Diego, California, United States of America.

Plos One
|November 19, 2013
PubMed

Insights

MicroRNA 122 (miR-122) acts as a tumor suppressor in liver cancer (HCC). By targeting AKT3, miR-122 inhibits cancer cell growth and migration, offering potential therapeutic strategies for hepatocellular carcinoma.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • MicroRNAs (miRNAs) regulate cellular processes and are implicated in cancer.
  • Hepatocellular carcinoma (HCC) often shows decreased levels of miR-122, a liver-specific miRNA.
  • The precise function of miR-122 in liver tumorigenesis is not fully understood.

Purpose of the Study:

  • To investigate the role of miR-122 in hepatocellular carcinoma.
  • To identify direct targets of miR-122 in HCC.
  • To evaluate miR-122 as a potential therapeutic agent for liver cancer.

Main Methods:

  • In vitro studies using HCC cell lines to assess miR-122 restoration effects.
  • Identification and validation of AKT3 as a direct miR-122 target.
  • In vivo xenograft mouse models to evaluate tumor growth inhibition.

Main Results:

  • Restoring miR-122 in HCC cells reduced AKT3 expression, inhibited cell migration and proliferation, and induced apoptosis.
  • AKT3 re-expression rescued the anti-tumor effects mediated by miR-122.
  • In vivo, miR-122 significantly inhibited HCC xenograft tumor growth.

Conclusions:

  • miR-122 functions as a tumor suppressor in HCC by targeting AKT3.
  • miR-122 plays a critical role in regulating HCC tumorigenesis.
  • miR-122 represents a promising therapeutic candidate for liver cancer treatment.

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.1K
Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.9K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K